Related Experiment Video
Updated: Jun 23, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB
Elsa Sánchez-López1, Sandra Rayego, Raquel Rodrigues-Díez
1Cellular Biology in Renal Diseases Laboratory, Universidad Autónoma Madrid, Madrid, Spain.
Abstract:
Connective tissue growth factor (CTGF) is an important profibrotic factor in kidney diseases. Blockade of endogenous CTGF ameliorates experimental renal damage and inhibits synthesis of extracellular matrix in cultured renal cells. CTGF regulates several cellular responses, including adhesion, migration, proliferation, and synthesis of proinflammatory factors. Here, we investigated whether CTGF participates in the inflammatory process in the kidney by evaluating the nuclear factor-kappa B (NF-kappaB) pathway, a key signaling system that controls inflammation and immune responses. Systemic administration of CTGF to mice for 24 h induced marked infiltration of inflammatory cells in the renal interstitium (T lymphocytes and monocytes/macrophages) and led to elevated renal NF-kappaB activity. Administration of CTGF increased renal expression of chemokines (MCP-1 and RANTES) and cytokines (INF-gamma, IL-6, and IL-4) that recruit immune cells and promote inflammation. Treatment with a NF-kappaB inhibitor, parthenolide, inhibited CTGF-induced renal inflammatory responses, including the up-regulation of chemokines and cytokines. In cultured murine tubuloepithelial cells, CTGF rapidly activated the NF-kappaB pathway and the cascade of mitogen-activated protein kinases, demonstrating crosstalk between these signaling pathways. CTGF, via mitogen-activated protein kinase and NF-kappaB activation, increased proinflammatory gene expression. These data show that in addition to its profibrotic properties, CTGF contributes to the recruitment of inflammatory cells in the kidney by activating the NF-kappaB pathway.
Insights
Connective tissue growth factor (CTGF) drives kidney inflammation by activating the nuclear factor-kappa B (NF-kappaB) pathway. Blocking NF-kappaB reduces CTGF-induced inflammatory cell recruitment and gene expression in the kidney.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Connective tissue growth factor (CTGF) is a key profibrotic factor in kidney disease.
- CTGF influences cellular processes like adhesion, migration, proliferation, and the synthesis of inflammatory factors.
Purpose of the Study:
- To investigate CTGF's role in kidney inflammation by examining its effect on the nuclear factor-kappa B (NF-kappaB) pathway.
- To determine if CTGF activates NF-kappaB signaling and contributes to inflammatory cell recruitment in the kidney.
Main Methods:
- Systemic administration of CTGF to mice and subsequent analysis of renal inflammatory cell infiltration and NF-kappaB activity.
- Measurement of renal chemokine and cytokine expression following CTGF administration.
- In vitro studies using cultured murine tubuloepithelial cells to assess CTGF's impact on NF-kappaB and mitogen-activated protein kinase (MAPK) pathways.
- Evaluation of the effects of a NF-kappaB inhibitor (parthenolide) on CTGF-induced renal inflammation.
Main Results:
- CTGF administration induced significant inflammatory cell infiltration (T lymphocytes, monocytes/macrophages) in the renal interstitium and elevated renal NF-kappaB activity.
- CTGF increased the expression of inflammatory chemokines (MCP-1, RANTES) and cytokines (INF-gamma, IL-6, IL-4) in the kidney.
- CTGF rapidly activated both the NF-kappaB and MAPK pathways in cultured renal cells, indicating pathway crosstalk.
- Inhibition of NF-kappaB significantly reduced CTGF-induced inflammatory responses, including chemokine and cytokine upregulation.
Conclusions:
- CTGF contributes to kidney inflammation by activating the NF-kappaB pathway.
- CTGF promotes the recruitment of inflammatory cells into the kidney through NF-kappaB and MAPK signaling.
- These findings highlight CTGF's dual role in kidney disease, encompassing both profibrotic and pro-inflammatory actions.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Acute Inflammation II: Cellular Phase
